Unfortunately, on Taxol I do not have that comparison. I do not think it is on my list, but the comparison is essentially the same. It is about three times more, or at least it was when it came off patent in the United States; it was more than three times more in the United States than they paid in Europe, and the American taxpayers paid for most of the R&D costs. By the GAO's own estimate, the taxpayers spent at least $484 million developing the drug, and I yield to my friend.
Gilbert Gutknecht: “Unfortunately, on Taxol I do not have that comparison. I do not think it is on my list, but the comparison is…”
Editor's note · Context
Discussing the cost of the drug Taxol and its development funding.
Share
More from Gilbert Gutknecht
Exactly. And not only are you a potential target, your family is a potential target. Most of us at one time in our political lives have had some goofball who has issued some kind of a death threat against us. Usually we don't even take it…
I would only close by saying that financial literacy clearly is an idea whose time has come. I thank the authors for bringing it forward. I urge all Members to support the adoption of House Resolution 148.
Sarajevo. I was in Sarajevo 10 years ago, and at that time the city was essentially in, the center city, essentially rubble. Many buildings had large pockmarks. Some of them are still there. Many, though, have been fixed; and it now is a…
I am going to close up here. If you have any closing thoughts, Chairman Hoekstra, go ahead. Then I am going to close up and yield it back here in just a few minutes.





